Table 1.
Patients (n) | 189 | |
Age (year) ± SD | 58 ± 18 | |
Sex (M/F) | 95/94 | |
ALT (U/L) ± SE | 142 ± 8 | |
AST (U/L) ± SE | 103 ± 7 | |
Genotype 1-4 vs others | 115 vs 74 | 61 vs 39% |
Anti-Hp positive antibody | 60 | 31.8% |
Gastrin (pg/ml)(median ± SE) | 52.0 ± 10.4 | |
TSH (UI/ml) | 2.2 ± 0.15 | |
ANA positive (n) | 34 | 18% |
AMA positive (n) | - | |
ASMA positive (n) | 57 | 30% |
LKM positive (n) | 1 | 0.5% |
APCA positive (n) | 3 | 1.6% |
ATM positive (n) | 15 | 7.8% |
Liver histology (n) | ||
CAH without cirrhosis (n) | 138 | 73% |
CAH with cirrhosis (n) | 51 | 27% |